RECURRENCE
Clinical trials for RECURRENCE explained in plain language.
Never miss a new study
Get alerted when new RECURRENCE trials appear
Sign up with your email to follow new studies for RECURRENCE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Common surgical drug may hold key to stopping lung Cancer's return
Disease control Not yet recruitingThis study is testing if giving the numbing drug lidocaine during and right after lung cancer surgery can help prevent the cancer from coming back or spreading. About 1,400 patients having minimally invasive surgery will be randomly assigned to receive either lidocaine or a place…
Matched conditions: RECURRENCE
Phase: NA • Sponsor: First Affiliated Hospital of Ningbo University • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
AI vs. liver cancer: can computers pick who needs treatment?
Disease control Not yet recruitingThis study aims to see if an artificial intelligence (AI) model can better identify which liver cancer patients need immunotherapy after surgery to prevent the cancer from coming back. It will follow 300 patients who have had their liver tumors surgically removed. The AI will ana…
Matched conditions: RECURRENCE
Sponsor: Tongji Hospital • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Virus injected into brain to fight deadly childhood tumors
Disease control Not yet recruitingThis study is testing a new treatment for aggressive brain tumors that have come back or stopped responding to standard treatments in children and young adults. It involves a single injection of a modified virus (DNX-2401) directly into the tumor during a biopsy procedure. The ma…
Matched conditions: RECURRENCE
Phase: PHASE2 • Sponsor: Clinica Universidad de Navarra, Universidad de Navarra • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
New blood test could predict liver Cancer's return after surgery
Diagnosis Not yet recruitingThis study is testing a new blood test that detects tiny amounts of leftover cancer cells after liver cancer surgery. Researchers want to see if this test can better predict which patients' cancer will return and identify who might benefit from additional immunotherapy treatment.…
Matched conditions: RECURRENCE
Phase: NA • Sponsor: Tongji Hospital • Aim: Diagnosis
Last updated Mar 09, 2026 14:22 UTC
-
Blood test trial aims to catch returning breast cancer months earlier
Knowledge-focused Not yet recruitingThis study is testing whether a new blood test can detect if triple-negative breast cancer is returning earlier than current standard scans. Thirty patients who have finished initial treatment will be randomly assigned to receive either standard follow-up care or standard care pl…
Matched conditions: RECURRENCE
Phase: NA • Sponsor: Sunnybrook Health Sciences Centre • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC